search
Back to results

A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter."

Primary Purpose

Urinary Retention, Urinary Bladder, Neurogenic, Intermittent Catheterization

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
C3 "UMBRELLA CATHETER"
Sponsored by
Dr. Gaines W. Hammond Jr. MD FACS
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Urinary Retention

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Patients with Bladder Dysfunction requiring mechanical drainage.
  2. Patients with actual urinary retention

Exclusion Criteria:

  1. Inability to undergo bladder catheterization (e.g., urethral stricture or history of urethral stricture)
  2. Gross hematuria

Sites / Locations

  • Watson Clinic LlpRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

C3 PATIENT PARTICIPANTS

Arm Description

This single arm prospective study is designed to produce valid scientific evidence regarding safety and efficacy of the C3 in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days in patients. The total study population will initially include 50 subjects with open enrollment of additional subjects.

Outcomes

Primary Outcome Measures

Catheterization of the bladder from an antegrade direction with the C3 device.
The percentage for patients enrolled in the student with the C3 inserted who are able to engage the tubular portion of the device into the bladder neck and urethra from the default position in the bladder with resultant drainage of the bladdder.
The retreat of the C3 back into the bladder from the engaged position
The percentage of enrolled patients who upon completion of bladder drainage with the engaged tubular portion of the C3 in bladder neck and urethral location retreats back into the default position in the bladder.

Secondary Outcome Measures

Reduction in Catheter Acquired Urinary Tract Infection Rate
The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) with the C3 "Umbrella Catheter" as compared to the expected incidence with either a Foley Catheter or Self Intermittent Catheter for bladder drainage.

Full Information

First Posted
October 24, 2017
Last Updated
November 20, 2017
Sponsor
Dr. Gaines W. Hammond Jr. MD FACS
search

1. Study Identification

Unique Protocol Identification Number
NCT03353571
Brief Title
A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter."
Official Title
A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter" for Patients With Urinary Retention Due to Bladder Dysfunction (C3 Catheter Study)
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Unknown status
Study Start Date
August 31, 2017 (Actual)
Primary Completion Date
March 2018 (Anticipated)
Study Completion Date
March 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Dr. Gaines W. Hammond Jr. MD FACS

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The Catheter Science C3 "Umbrella Catheter" has been developed for management of urinary retention in patients who are either using a Foley or Self Intermittent Catheter. This device is inserted into the bladder in an extended state and once the stylet is removed the device folds into collapsed state. A thread is attached to the device and traverses thru the urethra and is attached to a bobber. With gentle traction on the thread the device engages the bladder neck and the central tube extends which allows for the flow of urine. Once voiding is complete, the thread is released and the device collapses back to the folded state into the bladder. Each voiding cycle is accomplished in a similar fashion. This is a novel technique in which the bladder is catheterized with the device from within the bladder into the bladder neck and urethra. The standard self catheter technique is for placement of a catheter from the outside into the urethra and into the bladder.
Detailed Description
Interventional (clinical trial): Participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the effect of the intervention(s) on biomedical or other health related outcomes. This single arm, prospective study is designed to produce valid scientific evidence regarding: Safety and efficacy of the Catheter Science C3 "Umbrella Catheter" in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days. The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) A single arm study design was chosen because there is no alternative treatment to serve as an appropriate control. The C3 catheterizes the bladder with engagement into the bladder neck under the control of the patient or care giver. A Foley catheter, a pre- amendment device, was considered for a control treatment. However, although a Foley catheter is used to establish urinary drainage with close to 100% efficacy, it does not restore voiding function like the C3, and severely impairs activities of daily life. The intrinsic design flaws of a Foley catheter traversing thru the urinary passage which violates the anatomical protective points which help to avoid bacterial contamination. The distal 1/3 portion of the urethra in females is commonly colonized with bacteria. Standard Catheter technique traverses from the outside into the entire length of the urethra to drain the bladder. The standard self catheter flow characteristics are impacted due to the placements of the "eyes" to the catheter lumen. The C3 lumen is open in line with the flow.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Retention, Urinary Bladder, Neurogenic, Intermittent Catheterization

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Safety and efficacy of the Catheter Science C3 "Umbrella Catheter" in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days. The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) A single arm study design was chosen because there is no alternative treatment to serve as an appropriate control. The C3 catheterizes the bladder with engagement into the bladder neck under the control of the patient or care giver. A Foley catheter, a pre- amendment device, was considered for a control treatment. However, although a Foley catheter is used to establish urinary drainage with close to 100% efficacy, it does not restore voiding function like the C3, and severely impairs activities of daily life.
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
C3 PATIENT PARTICIPANTS
Arm Type
Other
Arm Description
This single arm prospective study is designed to produce valid scientific evidence regarding safety and efficacy of the C3 in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days in patients. The total study population will initially include 50 subjects with open enrollment of additional subjects.
Intervention Type
Device
Intervention Name(s)
C3 "UMBRELLA CATHETER"
Intervention Description
The C3 is an alternative method to facilitate bladder drainage in the study population which are using either a foley catheter or Clean Intermittent Catheter technique to drain the bladder.
Primary Outcome Measure Information:
Title
Catheterization of the bladder from an antegrade direction with the C3 device.
Description
The percentage for patients enrolled in the student with the C3 inserted who are able to engage the tubular portion of the device into the bladder neck and urethra from the default position in the bladder with resultant drainage of the bladdder.
Time Frame
Measurement of data points are collected sequentially every 7 days up to 28 days.
Title
The retreat of the C3 back into the bladder from the engaged position
Description
The percentage of enrolled patients who upon completion of bladder drainage with the engaged tubular portion of the C3 in bladder neck and urethral location retreats back into the default position in the bladder.
Time Frame
Measurement of data points are collected sequentially every 7 days up to 28 days.
Secondary Outcome Measure Information:
Title
Reduction in Catheter Acquired Urinary Tract Infection Rate
Description
The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) with the C3 "Umbrella Catheter" as compared to the expected incidence with either a Foley Catheter or Self Intermittent Catheter for bladder drainage.
Time Frame
Measurement of data points are collected sequentially every 7 days up to 28 days.

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients with Bladder Dysfunction requiring mechanical drainage. Patients with actual urinary retention Exclusion Criteria: Inability to undergo bladder catheterization (e.g., urethral stricture or history of urethral stricture) Gross hematuria
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
GAINES W HAMMOND, MD
Phone
863-680-7300
Email
GHAMMOND@WATSONCLINIC.COM
First Name & Middle Initial & Last Name or Official Title & Degree
ELAYNE HALL
Phone
863-680-7300
Email
EHALL@WATSONCLINIC.COM
Facility Information:
Facility Name
Watson Clinic Llp
City
Lakeland
State/Province
Florida
ZIP/Postal Code
33805
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
GAINES W HAMMOND, MD
Phone
863-680-7300
Email
GHAMMOND@WATSONCLINIC.COM
First Name & Middle Initial & Last Name & Degree
ELAYNE HALL
Phone
863-680-7300
Email
EHALL@WATSONCLINIC.COM

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
LISTED IN STUDY INFORMED CONSENT WITH NAME RECOGNITION WITHHELD
IPD Sharing Time Frame
After completion of the study which is anticipated to be March 2018 for a period of 2 years post completion.
IPD Sharing Access Criteria
Access with proper credentials with the patient identifying markers withheld.

Learn more about this trial

A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter."

We'll reach out to this number within 24 hrs